Billy Evans, partner of Elizabeth Holmes, has launched Haemanthus, an AI-powered biotech startup focusing on affordable medical testing. Utilizing Raman spectroscopy, the company aims to create commercially available diagnostic tools using various biological samples, including blood, sweat, urine, and saliva. Despite Holmes’s 11-year prison sentence for Theranos fraud, she reportedly advises Evans, though she is not formally involved in the company’s operations. Haemanthus hopes to significantly reduce the cost and accessibility barriers of this technology, currently utilized primarily in research settings.
Read More
User feedback revealed significant issues with video ad playback. Problems reported included slow loading, frozen or incomplete ads, and failure to initiate video content following the ad. Additionally, excessive audio volume was a common complaint. These issues highlight a need for improved video ad delivery and user experience.
Read More
Theranos fraudster Elizabeth Holmes has prison sentence reduced again. It seems like the justice system has once again favored the rich and powerful. Holmes, who was found guilty of defrauding wealthy individuals, is now scheduled for release earlier than expected. The fact that her sentence has been reduced by more than four months is disheartening, especially considering the magnitude of the damage she caused.
Holmes was ordered to pay a hefty sum of $452 million in restitution to those she defrauded, but a judge delayed those payments due to her “limited financial resources.” It is disappointing to see that even in the face of such a significant financial obligation, she seems to be getting away with it.… Continue reading
John Q. Hosedrinker